We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Breakthrough T1D Canada was proud to have representatives included in this important advocacy event. The Breakthrough T1D Children’s Congress advocacy program organized by Breakthrough T1D International in the United States, was inspired by a boy from Massachusetts named Tommy Solo (one of the type 1 diabetes (T1D) role models at the event). At age nine, […]
Breakthrough T1D Canada Board Member Matt Varey rode across Canada in support of type 1 diabetes (T1D) research On May 3, Matt Varey, a longtime volunteer with Breakthrough T1D Canada (formerly JDRF) and current Co-Chair of the Breakthrough T1D International Board, began a 61 day, 7400km+ journey to cycle across Canada. At 61, Matt had […]
The American Diabetes Association’s 85th Scientific Sessions were held from June 21- 24th, 2025. The research presented at ADA covers all areas of type 1 diabetes (T1D) developments, including devices, adjunct therapies and the latest in cell therapies. Updates in cell therapies research Dr. Andrew Pepper (Edmonton) presented on vascularization strategies to increase the survival […]
Guest post: Mark E. Paull, CME, Substack: adhd-t1dm.substack.com, Published Writer | Lived-Experience Advocate | Type 1 diabetes since 1967 | This is my experience. It may apply to others—perhaps we all share certain aspects of it—or it may not. The connections between ADHD, cognition, and perception need more research. What follows is not a claim, […]
Throughout June, thousands of supporters in nearly 50 communities gathered across the country to raise funds for type 1 diabetes (T1D) research. Breakthrough T1D Walk (formerly the JDRF Walk to Cure Diabetes) is the largest fundraising event in Canada that unites the T1D community who are dedicated to making every day better for the estimated […]
Dapagliflozin, an SGLT2i medication often used for people with type 2 diabetes, showed improved kidney function and glycemic management in teens with type 1 diabetes. This trial supports a growing body of evidence that supports the use of adjunctive therapies (drugs beyond insulin) for T1D. Adolescence can be a challenging time to manage type 1 […]
On Jan 7, 2025 (Sweden), Sana Biotechnology released significant clinical data: the first person with type 1 diabetes (T1D) who received deceased donor islets engineered to evade the immune system is producing insulin without immunosuppression. UPDATE: June 23, 2025Sana Biotechnology presented updated data on June 23, 2025 at the six-month follow up timepoint. The single patient dosed […]
Kendra Fisher is a former member of Team Canada’s hockey program, a 3x world inline hockey champion, and a firefighter. She is also the Founder of Mentally Fit; a professional speaker, a mental health coach, and an author in the making. Kendra may be best known for her hockey career, and for making the life-altering […]
We’ve made major progress in the development of cell replacement therapies for type 1 diabetes (T1D) over the past few decades – much of it right here in Canada. We know that manufactured islets can be safely implanted into people, where they start to make insulin. But there is more work to do to advance […]
Jim Beatty is a passionate volunteer in the fight against type 1 diabetes. For many years, Jim has volunteered with the JDRF, and now Breakthrough T1D, emceeing events and participating on various committees. Jim has been living with type 1 diabetes for more than 20 years, following his adult diagnosis. Jim is a former journalist […]
We are pleased to announce 6 new grants funded via Breakthrough T1D International (USA) to stellar Canadian scientists. These grants all support cell therapy research to replace insulin-producing cells in people living with T1D. Dr. Cristina Nostro, University Health Network (Toronto) Manufacturing clinical-grade stem cell-derived islets – 2 Grants To date, global efforts on this […]
Type 1 in year 1: turning the page on an unexpected diagnosis at university Meet Aryssah, an incredibly resilient adult living with type 1 diabetes (T1D). She is a committed $100M Campaign to Accelerate volunteer and champion of diabetes and mental health support. She devotes her time to appreciating the incredible philanthropic donors who help […]
Notifications
